Machine learning (ML) has been recently introduced to develop prognostic classification models that can be used to predict outcomes in individual cancer patients. Here, we report the significance of an ML-based decision support system (DSS), combined with random optimization (RO), to extract prognostic information from routinely collected demographic, clinical and biochemical data of breast cancer (BC) patients. A DSS model was developed in a training set (n = 318), whose performance analysis in the testing set (n = 136) resulted in a C-index for progression-free survival of 0.84, with an accuracy of 86%. Furthermore, the model was capable of stratifying the testing set into two groups of patients with low- or high-risk of progression with a hazard ratio (HR) of 10.9 (p < 0.0001). Validation in multicenter prospective studies and appropriate management of privacy issues in relation to digital electronic health records (EHR) data are presently needed. Nonetheless, we may conclude that the implementation of ML algorithms and RO models into EHR data might help to achieve prognostic information, and has the potential to revolutionize the practice of personalized medicine.

Ferroni, P., Zanzotto, F.m., Riondino, S., Scarpato, N., Guadagni, F., Roselli, M. (2019). Breast Cancer Prognosis Using a Machine Learning Approach. CANCERS, 11(3), 328 [10.3390/cancers11030328].

Breast Cancer Prognosis Using a Machine Learning Approach

Zanzotto, Fabio M;Riondino, Silvia;Roselli, Mario
2019-03-07

Abstract

Machine learning (ML) has been recently introduced to develop prognostic classification models that can be used to predict outcomes in individual cancer patients. Here, we report the significance of an ML-based decision support system (DSS), combined with random optimization (RO), to extract prognostic information from routinely collected demographic, clinical and biochemical data of breast cancer (BC) patients. A DSS model was developed in a training set (n = 318), whose performance analysis in the testing set (n = 136) resulted in a C-index for progression-free survival of 0.84, with an accuracy of 86%. Furthermore, the model was capable of stratifying the testing set into two groups of patients with low- or high-risk of progression with a hazard ratio (HR) of 10.9 (p < 0.0001). Validation in multicenter prospective studies and appropriate management of privacy issues in relation to digital electronic health records (EHR) data are presently needed. Nonetheless, we may conclude that the implementation of ML algorithms and RO models into EHR data might help to achieve prognostic information, and has the potential to revolutionize the practice of personalized medicine.
7-mar-2019
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/06 - ONCOLOGIA MEDICA
English
artificial intelligence; breast cancer prognosis; decision support systems; machine learning
Ferroni, P., Zanzotto, F.m., Riondino, S., Scarpato, N., Guadagni, F., Roselli, M. (2019). Breast Cancer Prognosis Using a Machine Learning Approach. CANCERS, 11(3), 328 [10.3390/cancers11030328].
Ferroni, P; Zanzotto, Fm; Riondino, S; Scarpato, N; Guadagni, F; Roselli, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Ferroni, Cancers 2019.pdf

accesso aperto

Licenza: Creative commons
Dimensione 479.63 kB
Formato Adobe PDF
479.63 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/211455
Citazioni
  • ???jsp.display-item.citation.pmc??? 42
  • Scopus 120
  • ???jsp.display-item.citation.isi??? 83
social impact